Clustering data with hclust algorithm for Differences in bile acids composition between ASCL5 knockout and floxed mice. (Study ST000694)

Reversed phase NEGATIVE ION MODE (Analysis AN001073)
MetaboliteStructureF1F2F3F4F5F6F7F8
2-HYDROXY-3-METHYLBUTYRIC ACID (CAS# 4026-18-0); (M-H)-ME1947140.700.561.12NA0.631.831.12NA
3-(4-HYDROXYPHENYL)LACTATE (CAS# 6482-98-0); (M-H)-ME1947220.470.760.61NA0.371.960.93NA
ADENOSINE 5^-MONOPHOSPHATE (CAS# 61-19-8); (M-H)-ME1947610.611.350.77NA0.990.351.16NA
4-HYDROXY-2-QUINOLINECARBOXYLIC ACID-KRYNURENIC ACID (CAS# 492-27-3); (M-H)-ME1947370.390.660.83NA0.311.901.14NA
ADENOSINE (CAS# 58-61-7); (M+HCOO)-ME1947600.120.891.39NA0.331.070.91NA
5^-METHYLTHIOADENOSINE (CAS# 2457-80-9); (M+CL)-ME1947470.720.721.46NA0.760.521.47NA
4-METHYL-2-OXOPENTANOATE (CAS# 816-66-0); (M-H)-ME1947400.850.481.19NA0.821.131.27NA
2-DEOXY-D-GLUCOSE (CAS# 154-17-6); (M+HCOO)-ME1947131.200.071.05NA0.461.36NANA
4-COUMARATE (CAS# 501-98-4); (M-H)-ME1947361.351.170.99NA0.531.080.85NA
2^-DEOXYINOSINE (CAS# 890-38-0); (M-H)-ME194711NA0.971.15NANA0.831.24NA
5-OXOPROLINE (CAS# 4042-36-8); (M-H)-ME1947550.990.971.17NA0.481.370.74NA
ALLOSE (CAS# 2595-97-3); (M-H)+[-H2O]ME1947651.530.880.56NA1.710.650.85NA
5^-METHYLTHIOADENOSINE (CAS# 2457-80-9); (M+HCOO)-ME1947480.581.201.00NA0.791.271.16NA
4-PYRIDOXATE (CAS# 82-82-6); (M-H)-ME1947450.661.261.44NA0.521.160.99NA
4-NITROPHENOL (CAS# 100-02-7); (M-H)-ME1947440.981.320.99NA0.930.870.94NA
4-ACETAMIDOBUTANOATE (CAS# 3025-96-5); (M-H)-ME1947340.863.140.98NANA0.950.43NA
16:0 LYSO PC (CAS# 17364-16-8); (M+HCOO)-ME1947041.280.241.49NA1.350.401.24NA
2^-DEOXYGUANOSINE (CAS# 961-07-9); (M+CL)-ME194708NA0.971.48NA0.150.571.46NA
4-METHYL-2-OXOVALERIC ACID (CAS# 816-66-0); (M-H)-ME1947410.850.481.19NA0.821.131.27NA
2-OXOADIPATE (CAS# 3184-35-8); (M-H)-ME1947180.79NANANA0.761.670.79NA
4-HYDROXYBENZOATE (CAS# 99-96-7); (M-H)-ME1947380.930.940.37NA0.901.350.20NA
2^-DEOXYGUANOSINE (CAS# 961-07-9); (M-H)-ME194709NA0.780.52NANA0.911.37NA
2-DEOXY-D-GLUCOSE (CAS# 154-17-6); (M+CL)-ME1947121.350.370.73NA1.191.490.83NA
5-AMINOPENTANOATE (CAS# 660-88-8); (M-H)-ME1947491.740.740.84NA1.200.600.86NA
3-HYDROXY-3-METHYLGLUTARATE (CAS# 503-49-1); (M-H)-ME1947251.680.760.63NA1.360.820.83NA
ARACHIDONATE (CAS# 506-32-1); (M-H)-ME1947712.320.451.03NA1.260.440.59NA
ADIPIC ACID (CAS# 124-04-9 ); (M-H)-ME1947620.961.580.95NA0.900.640.88NA
6-HYDROXYNICOTINATE (CAS# 5006-66-6); (M-H)-ME1947570.950.720.92NA0.431.391.10NA
3-(4-HYDROXYPHENYL)PYRUVATE (CAS# 156-39-8 ); (M-H)-ME194723NA0.031.10NA2.000.751.18NA
2-HYDROXY-4-(METHYLTHIO)BUTYRIC ACID (CAS# 583-91-5); (M-H)-ME1947151.21NA0.63NA1.181.530.36NA
2-METHYLGLUTARIC ACID (CAS# 18069-17-5); (M-H)-ME1947160.961.580.96NA0.900.640.87NA
ALPHA-LINOLENIC ACID (CAS# 463-40-1); (M+HCOO)-ME1947681.151.060.86NA0.951.000.98NA
5-HYDROXYTRYPTOPHAN (CAS# 4350-09-8); (M-H)-ME1947532.100.201.12NA1.370.351.03NA
ARACHIDIC ACID (CAS# 506-30-9); (M-H)-ME1947700.770.890.96NA0.731.490.66NA
ALPHA-D-GALACTOSE 1-PHOSPHATE (CAS# 2255-14-3); (M-H)-ME1947661.96NA0.92NA0.17NA0.08NA
16:0 LYSO PC (CAS# 17364-16-8); (M+CL)-ME1947031.350.401.53NA0.690.280.85NA
ADENOSINE (CAS# 58-61-7); (M+CL)-ME194759NA0.971.48NA0.150.571.46NA
ALLANTOIN (CAS# 97-59-6); (M-H)-ME1947640.771.100.93NA0.671.471.36NA
3-METHYLADIPIC ACID (CAS# 3058-01-3); (M-H)-ME1947300.851.131.09NA0.860.951.08NA
10-HYDROXYDECANOATE (CAS# 1679-53-4); (M-H)-ME1947000.521.18NANA1.600.84NANA
1-METHYLADENOSINE (CAS# 15763-06-1); (M+CL)-ME1946970.920.980.89NA1.060.431.24NA
3-METHYGLUTARIC ACID (CAS# 626-51-7); (M-H)-ME1947290.971.590.95NA0.900.640.87NA
18:0 LYSO-PE (CAS# 69747-55-3); (M-H)-ME1947060.920.730.70NA1.061.540.98NA
1-METHYLURIC ACID (CAS# 708-79-2); (M-H)-ME194698NA0.690.88NA1.141.350.25NA
6-CARBOXYHEXANOATE (CAS# 111-16-0); (M-H)-ME1947560.851.141.10NA0.790.991.09NA
5^-DEOXYADENOSINE (CAS# 4754-39-6); (M+HCOO)-ME194746NA0.940.98NA0.841.10NANA
3BETA-HYDROXY-5ALPHA-PREGNAN-20-ONE (CAS# 516-55-2); (M+CL)-[-H2O]ME1947320.560.860.51NA0.860.941.31NA
4-NITROBENZOIC ACID (CAS# 62-23-7); (M-H)-ME1947420.701.031.65NA0.960.910.91NA

Factors:

F1Genotype:FLOX | Intestinal Segment:Duodenum
F2Genotype:FLOX | Intestinal Segment:Illeum
F3Genotype:FLOX | Intestinal Segment:Jejunum
F4Genotype:- | Intestinal Segment:-
F5Genotype:Knockout | Intestinal Segment:Duodenum
F6Genotype:Knockout | Intestinal Segment:Illeum
F7Genotype:Knockout | Intestinal Segment:Jejunum
F8Genotype:Pooled flushing | Intestinal Segment:Pooled flushing
Data matrix
  logo